Association of FGFR4 Mutation With Immunotherapy Outcomes in Patients With Cancer

被引:0
|
作者
Cui, L. [1 ]
Zhang, Y. [1 ]
Zhao, Z. [2 ]
Bai, Y. [1 ]
Liu, L. [3 ]
机构
[1] 3D Med Inc, Dept Med, Shanghai, Peoples R China
[2] 3D Med Inc, Shanghai, Peoples R China
[3] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Shanghai, Peoples R China
关键词
FGFR4; immunotherapy;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P75.07
引用
收藏
页码:S576 / S576
页数:1
相关论文
共 50 条
  • [21] Impact of FGFR4 Gene Polymorphism on the Progression of Colorectal Cancer
    Shiu, Bei-Hao
    Hsieh, Ming-Hong
    Ting, Wen-Chien
    Chou, Ming-Chih
    Chang, Lun-Ching
    Huang, Chi-Chou
    Su, Shih-Chi
    Yang, Shun-Fa
    DIAGNOSTICS, 2021, 11 (06)
  • [22] FGFR4 Y367C: Contributes to a constitutively active FGFR4 and tumor aggressiveness in breast cancer cell line
    Foo, P.
    Ho, H. K.
    Streit, S.
    Ruhe, J. E.
    Hart, S.
    Ullrich, A.
    EJC SUPPLEMENTS, 2008, 6 (12): : 114 - 114
  • [23] The effect of FGFR4 Gly388Arg polymorphism on treatment outcomes after chemoradiotherapy in esophageal cancer patients.
    Cho, Sanghee
    Shim, Hyung-Jung
    Hwang, Jun-Eul
    Bae, Woo Kyun
    Nam, Taek-Keun
    Shin, Min-Ho
    Jung, Sook-In
    Oh, In-Jae
    Chung, Ik-Joo
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [24] Association between FGFR4 gene polymorphism and high-risk HPV infection cervical cancer
    Ya-Ping Li
    Lin Zhang
    Yu-Liang Zou
    Yan Yu
    Asian Pacific Journal of Tropical Medicine, 2017, (07) : 742 - 746
  • [25] Association between FGFR4 gene polymorphism and high-risk HPV infection cervical cancer
    Li, Ya-Ping
    Zhang, Lin
    Zou, Yu-Liang
    Yu, Yan
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2017, 10 (07) : 742 - 746
  • [26] Alteration in the serum concentrations of FGF19, FGFR4 and βKlotho in patients with thyroid cancer
    Motylewska, Ewelina
    Stepien, Tomasz
    Borkowska, Magdalena
    Kuzdak, Krzysztof
    Siejka, Agnieszka
    Komorowski, Jan
    Stepien, Henryk
    Lawnick, Hanna
    CYTOKINE, 2018, 105 : 32 - 36
  • [27] FGFR4 and Klotho Polymorphisms Are Not Associated with Cardiovascular Outcomes in Chronic Kidney Disease
    Sellier, Alexander B.
    Seiler-Mussler, Sarah
    Emrich, Insa E.
    Boehm, Michael
    Fliser, Danilo
    Zawada, Adam M.
    Heine, Gunnar H.
    AMERICAN JOURNAL OF NEPHROLOGY, 2021, 52 (10-11) : 808 - 816
  • [28] EGFR Inhibition Overcomes Resistance to FGFR4 Inhibition and Potentiates FGFR4 Inhibitor Therapy in Hepatocellular Carcinoma
    Shen, Bin
    Shi, Jue-Ping
    Zhu, Zhi-Xuan
    He, Zhi-Dong
    Liu, Shen-Yan
    Shi, Wan
    Zhang, Yong-Xian
    Ying, Hai-Yan
    Wang, Jie
    Xu, Rui-Feng
    Fang, Fei
    Chang, Harrison Xuesong
    Chen, Zhui
    Zhang, Nan-Nan
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12) : 1479 - 1492
  • [29] FGFR4 Links Glucose Metabolism and Chemotherapy Resistance in Breast Cancer
    Xu, Min
    Chen, Shuzheng
    Yang, Weibin
    Cheng, Xue
    Ye, Yani
    Mao, Jianting
    Wu, Xulu
    Huang, Li
    Ji, Jiansong
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 47 (01) : 151 - 160
  • [30] Glycosylation of FGFR4 in cholangiocarcinoma regulates receptor processing and cancer signaling
    Phillips, Andrew J.
    Lobl, Marissa B.
    Hafeji, Yamnah A.
    Safranek, Hannah R.
    Mohr, Ashley M.
    Mott, Justin L.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2022, 123 (03) : 568 - 580